Arkolith/Insider Trading/PAHC/Form 4

Bendheim Jack

President and CEO, Director, 10% OwnerPHIBRO ANIMAL HEALTH CORP (PAHC) · full profile →Form 4 · filed Nov 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$297K
Net Open-Market Flow
-$297K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 5, 2025Sell(S)3K$40.98$104K63K
Nov 5, 2025Sell(S)972$41.83$41K62K
Nov 4, 2025Conversion(C)25K—$069K
Nov 4, 2025Sell(S)524$43.62$23K66K
Nov 4, 2025Sell(S)3K$43.01$129K66K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 4, 2025Conversion(C)25K—$020.1M

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-107913) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML